Oxcarbazepine
NDC Package 81033-113-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy). Marketed by Kesin Pharma, this product is identified by NDC 81033-113 and is authorized under FDA application ANDA209652.

Identification & Billing

NDC Package Code
81033-113-30
Package Description
30 CUP, UNIT-DOSE in 1 CARTON / 5 mL in 1 CUP, UNIT-DOSE (81033-113-05)
Product Code
81033-113
11-Digit Billing Format
81033011330
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Oxcarbazepine
Dosage Form
-
Usage Information
Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Regulatory & Marketing

Labeler Name
Kesin Pharma
FDA Application #
ANDA209652
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-14-2023
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81033-113-30 identifies a specific commercial package of 30 cup, unit-dose in 1 carton / 5 ml in 1 cup, unit-dose (81033-113-05) of Oxcarbazepine, labeled by Kesin Pharma. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kesin Pharma on February 14, 2023. The current certification is valid through December 31, 2025.

What are the primary indications for this medication?

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

How is this Kesin Pharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033011330. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81033-113-30
11-Digit CMS (5-4-2)
81033-0113-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.